Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Technical Innovations & Patient Support in Radiation Oncology
|
September 30, 2021
A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices
D B Raphael, N S Russell, B Winkens, et al.
International Journal of Radiation Biology
|
June 24, 2000
Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations
A Broeks, N S Russell, A N Floore, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 6, 2008
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]
M E Straver, J C van Adrichem, E J Th Rutgers, et al.
Breast Cancer Research and Treatment
|
October 25, 2020
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial
D B Raphael Daniela, N S Russell, E van Werkhoven, et al.
Breast (Edinburgh, Scotland)
|
April 17, 2020
Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?
D B Raphael, N S Russell, J M Immink, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 8, 2022
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences
L J Boersma, M G A Sattler, J H Maduro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Technical Innovations & Patient Support in Radiation Oncology
|
September 30, 2021
A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices
D B Raphael, N S Russell, B Winkens, et al.
International Journal of Radiation Biology
|
June 24, 2000
Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations
A Broeks, N S Russell, A N Floore, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 6, 2008
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]
M E Straver, J C van Adrichem, E J Th Rutgers, et al.
Breast Cancer Research and Treatment
|
October 25, 2020
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial
D B Raphael Daniela, N S Russell, E van Werkhoven, et al.
Breast (Edinburgh, Scotland)
|
April 17, 2020
Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?
D B Raphael, N S Russell, J M Immink, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 8, 2022
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences
L J Boersma, M G A Sattler, J H Maduro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Page
of 4